November 23, 2017 / 5:24 AM / in 23 days

BRIEF-Biocon ‍launches Krabeva in India​

Nov 23 (Reuters) - Biocon Ltd:

* Launches Krabeva - biosimilar Bevacizumab for treating several types of cancer in India​

Source text - bit.ly/2jOug4x

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below